Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology
Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology
Active, not recruiting · NCT05768776 · Registry updated 2025-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Neoplasms, Multiple Primary, Urogenital Diseases, benign prostatic hyperplasia, endocrine system disorder, hereditary disease, hereditary neoplastic syndrome, male reproductive system disorder, malignant endocrine neoplasm, multiple endocrine neoplasia, multiple endocrine neoplasia type 1, neoplasm, prostate disorder | Active, not recruiting | Not stated | 2025-06-25 | NCT05768776 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital, Bordeaux | 221 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU de Bordeaux | Bordeaux | France | 1 |